BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 33164231)

  • 1. TGF-β1 and IL-17A comediate the protumor phenotype of neutrophils to regulate the epithelial-mesenchymal transition in oral squamous cell carcinoma.
    Yu T; Tang Q; Chen X; Fan W; Zhou Z; Huang W; Liang F
    J Oral Pathol Med; 2021 Apr; 50(4):353-361. PubMed ID: 33164231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FERMT1 knockdown inhibits oral squamous cell carcinoma cell epithelial-mesenchymal transition by inactivating the PI3K/AKT signaling pathway.
    Wang X; Chen Q
    BMC Oral Health; 2021 Nov; 21(1):598. PubMed ID: 34814915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IncRNA ZNF667-AS1 Suppresses Epithelial Mesenchymal Transformation by Targeting TGF-β1 in Oral Squamous Cell Carcinoma.
    Zhao J; Cui Z; Dong Z; Niu Y; Yang K; Han H
    Clin Lab; 2021 Jul; 67(7):. PubMed ID: 34258957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial-mesenchymal transition in oral squamous cell carcinoma triggered by transforming growth factor-beta1 is Snail family-dependent and correlates with matrix metalloproteinase-2 and -9 expressions.
    Qiao B; Johnson NW; Gao J
    Int J Oncol; 2010 Sep; 37(3):663-8. PubMed ID: 20664935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of transforming growth factor-beta1 by circANKS1B/miR-515-5p affects the metastatic potential and cisplatin resistance in oral squamous cell carcinoma.
    Yan J; Xu H
    Bioengineered; 2021 Dec; 12(2):12420-12430. PubMed ID: 34781814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naa10p and IKKα interaction regulates EMT in oral squamous cell carcinoma via TGF-β1/Smad pathway.
    Lv S; Luo T; Yang Y; Li Y; Yang J; Xu J; Zheng J; Zeng Y
    J Cell Mol Med; 2021 Jul; 25(14):6760-6772. PubMed ID: 34060226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
    Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
    Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-β1 activates ΔNp63/c-Myc to promote oral squamous cell carcinoma.
    Hu L; Liu J; Li Z; Wang C; Nawshad A
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Oct; 122(4):460-482.e4. PubMed ID: 27567435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of VAP-1 in OSCC suppresses tumor growth and metastasis via NF-κB/IL-8 signaling and reduces neutrophil infiltration.
    Xu Q; Chen X; Yu T; Tang Q; Zhou Z; Wang H; Huang W; Huang T; Liang F
    J Oral Pathol Med; 2022 Apr; 51(4):332-341. PubMed ID: 35174543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p130Cas induces bone invasion by oral squamous cell carcinoma by regulating tumor epithelial-mesenchymal transition and cell proliferation.
    Yaginuma T; Gao J; Nagata K; Muroya R; Fei H; Nagano H; Chishaki S; Matsubara T; Kokabu S; Matsuo K; Kiyoshima T; Yoshioka I; Jimi E
    Carcinogenesis; 2020 Aug; 41(8):1038-1048. PubMed ID: 31996896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral squamous cell carcinoma-derived EVs promote tumor progression by regulating inflammatory cytokines and the IL-17A-induced signaling pathway.
    Li R; Zhou Y; Zhang M; Xie R; Duan N; Liu H; Qin Y; Ma J; Li Z; Ye P; Wang W; Wang X
    Int Immunopharmacol; 2023 May; 118():110094. PubMed ID: 37030119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of disulfiram on epithelial-mesenchymal transformation of oral squamous cell carcinoma cells].
    Wang XM; Jiang Y
    Shanghai Kou Qiang Yi Xue; 2020 Apr; 29(2):138-145. PubMed ID: 32626875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1.
    Chen L; Zhu Q; Lu L; Liu Y
    Bioengineered; 2020 Dec; 11(1):91-102. PubMed ID: 31906769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mesenchymal stem cells are recruited via CXCL8-CXCR2 and promote EMT through TGF-β signal pathways in oral squamous carcinoma.
    Meng L; Zhao Y; Bu W; Li X; Liu X; Zhou D; Chen Y; Zheng S; Lin Q; Liu Q; Sun H
    Cell Prolif; 2020 Aug; 53(8):e12859. PubMed ID: 32588946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-495 confers inhibitory effects on cancer stem cells in oral squamous cell carcinoma through the HOXC6-mediated TGF-β signaling pathway.
    You X; Zhou Z; Chen W; Wei X; Zhou H; Luo W
    Stem Cell Res Ther; 2020 Mar; 11(1):117. PubMed ID: 32171324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β1 induces amoeboid-to-mesenchymal transition of CD44
    Yokoyama S; Shigeishi H; Murodumi H; Sakuma M; Kato H; Higashikawa K; Ohta K; Sugiyama M; Takechi M
    J Oral Pathol Med; 2021 Feb; 50(2):155-164. PubMed ID: 33107637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-cell analysis reveals that cancer-associated fibroblasts stimulate oral squamous cell carcinoma invasion via the TGF-β/Smad pathway.
    Yang W; Zhang S; Li T; Zhou Z; Pan J
    Acta Biochim Biophys Sin (Shanghai); 2022 Sep; 55(2):262-273. PubMed ID: 36148955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quercetin Inhibits Cell Survival and Metastatic Ability via the EMT-mediated Pathway in Oral Squamous Cell Carcinoma.
    Kim SR; Lee EY; Kim DJ; Kim HJ; Park HR
    Molecules; 2020 Feb; 25(3):. PubMed ID: 32050534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-β1/Smad signaling pathway regulates epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma: in vitro and clinical analyses of cell lines and nomadic Kazakh patients from northwest Xinjiang, China.
    Pang L; Li Q; Wei C; Zou H; Li S; Cao W; He J; Zhou Y; Ju X; Lan J; Wei Y; Wang C; Zhao W; Hu J; Jia W; Qi Y; Liu F; Jiang J; Li L; Zhao J; Liang W; Xie J; Li F
    PLoS One; 2014; 9(12):e112300. PubMed ID: 25464508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-β-regulated fractalkine as a marker of erosive bone invasion in oral squamous cell carcinoma.
    Son SH; Park J; Jung MJ; Lee SK; Kim H; Kim KR; Park KK; Chung WY
    Eur J Oral Sci; 2021 Feb; 129(1):e12750. PubMed ID: 33503283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.